V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240001054 | 240011353 | 1.68 | 125.5 | Curative (C) | 2018-03-06 | 2018-03-06 | Hydroxycarbamide | 01 | null | HYDROXYCARBAMIDE | 101319744 |
| 240001062 | 240011354 | 1.58 | 62 | Curative (C) | 2017-05-13 | 2017-05-23 | Hydroxycarbamide | N | N | AML19 TRIAL | 100735980 |
| 240001063 | 240011355 | 1.34 | 62.8 | 03 | 2020-09-16 | 2020-09-17 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 101858513 |
| 240001078 | 240011357 | 1.78 | 149 | null | 2020-05-20 | 2020-05-30 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | null | RITUXIMAB | 101535892 |
| 240001095 | 240011361 | 0 | 64.3 | Curative (C) | null | 2018-06-07 | null | null | N | RITUXIMAB | 101404275 |
| 240001101 | 240011362 | null | null | Adjuvant (A) | 2021-12-20 | 2021-12-20 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100498941 |
| 240001136 | 240011364 | 1.78 | 119.3 | null | 2021-04-21 | 2021-04-23 | AML 18 TRIAL | null | N | CHOP R | 100821053 |
| 240001153 | 240011365 | null | null | 03 | 2019-11-11 | 2019-11-11 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100890892 |
| 240001173 | 240011366 | 0 | 52.6 | null | null | 2016-11-06 | null | null | null | METHOTREXATE | 101104922 |
| 240001183 | 240011368 | 1.83 | 88.6 | null | null | 2020-01-24 | null | 02 | null | CYTARABINE | 101714641 |
| 240001204 | 240011370 | 1.63 | 84 | Palliative (P) | 2022-03-18 | 2022-03-25 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 101606493 |
| 240001218 | 240011372 | 1.68 | 95.8 | null | null | 2016-03-30 | null | 02 | null | AZACITIDINE | 100712909 |
| 240001289 | 240011376 | null | null | null | 2021-07-08 | 2021-07-08 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100756944 |
| 240001301 | 240011377 | 1.32 | 0 | null | null | 2019-12-06 | null | null | null | RITUXIMAB | 101465330 |
| 240001319 | 240011379 | 1.65 | 76.7 | null | 2019-12-14 | 2019-12-16 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101043596 |
| 240001354 | 240011382 | 1.7 | 76.2 | null | 2018-11-24 | 2018-11-26 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101747465 |
| 240001364 | 240011383 | 1.8 | 81.6 | Curative (C) | null | 2020-03-25 | null | 02 | null | BENDAMUSTINE + RITUXIMAB | 101067219 |
| 240001372 | 240011385 | 1.62 | 62.4 | null | 2019-06-01 | 2019-06-01 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 100692052 |
| 240001430 | 240011387 | null | 69 | null | null | 2020-03-21 | null | 02 | null | HYDROXYCARBAMIDE | 101367622 |
| 240001436 | 240011388 | 1.54 | 50 | null | null | 2021-01-06 | Hydroxycarbamide | null | N | AML18 TRIAL | 100913396 |
| 240001468 | 240011390 | 1.78 | 114 | null | 2021-02-12 | 2021-02-15 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | null | RITUXIMAB | 100515500 |
| 240001526 | 240011392 | 1.8 | 67.3 | Curative (C) | null | 2020-07-24 | ALL UKALL2011 IndB Std Dex (PegAsp) | 02 | N | CYTARABINE HIGH DOSE | 100399158 |
| 240001539 | 240011393 | null | 20.6 | null | 2016-09-14 | 2016-09-17 | CNS LGG 2004 03 vinc weekly+ carbo | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE | 101163127 |
| 240001749 | 240011397 | 1.74 | 97 | null | 2021-10-13 | 2021-10-16 | ALL UKALL2011 Maintenance A4 | 01 | null | MELPHALAN | 101345435 |
| 240001809 | 240011398 | 1.78 | 86.95 | null | 2022-01-31 | 2022-03-09 | FLAIR trial | 02 | null | CYTARABINE + DAUNORUBICIN | 100465468 |
| 240001816 | 240011399 | 0 | 74.1 | null | 2020-06-20 | 2020-06-25 | R CODOX M | Y | null | CLADRIBINE | 101132644 |
| 240001837 | 240011401 | 1.7 | 0 | null | 2022-04-27 | 2022-05-01 | BEAM | 02 | null | CHLORAMBUCIL | 100257094 |
| 240001892 | 240011404 | 1.79 | 71.2 | null | 2020-10-02 | 2020-10-05 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | BUSULFAN | 100899672 |
| 240001922 | 240011406 | 1.67 | 145 | null | 2019-11-13 | 2020-01-31 | Alemtuzumab + Cyclophos TBI Allo | 01 | null | CYCLOPHOSPHAMIDE | 101630483 |
| 240001939 | 240011407 | 1.66 | 99.9 | Curative (C) | 2022-03-22 | 2022-03-27 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100741940 |
| 240001964 | 240011408 | 1.89 | 96.7 | null | 2017-07-16 | 2017-08-12 | null | 01 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101222255 |
| 240002034 | 240011411 | 1.53 | 63.1 | Palliative (P) | 2019-08-31 | 2019-08-31 | FLAIR trial | 01 | N | CISPLATIN + GEMCITABINE | 100494626 |
| 240002062 | 240011414 | 1.57 | 57.9 | null | 2022-02-23 | 2022-02-27 | null | 2 | null | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 101172936 |
| 240002063 | 240011415 | 1.64 | 133.6 | null | 2018-10-07 | 2018-12-04 | null | N | null | GEMTUZUMAB OZOGAMICIN | 100752132 |
| 240002093 | 240011416 | 1.12 | 97 | Palliative (P) | 2017-02-08 | 2017-03-13 | Cladribine (subcut) 5 days | 01 | N | METHOTREXATE + VINBLASTINE | 100488667 |
| 240002109 | 240011417 | null | null | Curative (C) | 2019-06-27 | 2019-07-21 | DA 3 + 10 | 02 | N | CYCLOPHOSPHAMIDE | 100399769 |
| 240002171 | 240011421 | 1.62 | 84.8 | Curative (C) | null | 2020-11-28 | null | null | null | TRANSPLANT BUSULFAN + CYCLOPHOSPHAMIDE | 101783614 |
| 240002174 | 240011422 | 1.64 | 86.5 | null | 2021-11-08 | 2021-11-08 | ANAGRELIDE | Y | null | CISPLATIN + GEMCITABINE | 100903268 |
| 240002188 | 240011423 | 1.62 | 81.6 | Palliative (P) | null | 2020-01-05 | IBRUTINIB | null | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100775225 |
| 240002206 | 240011425 | 1.55 | 62 | null | 2021-09-14 | 2021-09-16 | FLAIR trial | 02 | null | PEG INTERFERON | 101859904 |
| 240002224 | 240011426 | 1.83 | 60.8 | null | 2021-04-22 | 2021-04-22 | R IVAC | 02 | Y | AML MYECHILD 01 FLA-IDARUBICIN | 100606828 |
| 240002282 | 240011430 | 1.82 | 49.6 | null | 2019-10-29 | 2019-12-07 | null | 02 | null | AML INTERIM GUIDELINES FLAG-IDA | 101256721 |
| 240002287 | 240011431 | 1.79 | 90.3 | Disease modification (D) | 2018-05-04 | 2018-07-13 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | 02 | null | DABRAFENIB | 101567333 |
| 240002298 | 240011432 | 1.81 | 82.8 | 03 | 2021-12-29 | 2022-01-02 | IBRUTINIB | 02 | N | ALL ALLR3: S/IR: INTENS | 100054492 |
| 240002351 | 240011434 | 1.78 | 133.4 | null | 2018-05-03 | 2018-05-25 | null | 02 | N | CYTARABINE + DAUNORUBICIN | 100578083 |
| 240002374 | 240011435 | null | null | Curative (C) | 2020-08-12 | 2020-09-09 | INTERFERON | 02 | null | CNS HGG TEMOZOLOMIDE +XRT | 100187681 |
| 240002391 | 240011436 | 1.5 | 17 | null | 2021-05-14 | 2021-05-15 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | null | CHLORAMBUCIL + RITUXIMAB | 101179262 |
| 240002430 | 240011438 | null | 82.6 | null | 2020-08-27 | 2020-09-02 | ALL UKALL2011 Maintenance B1 | 02 | null | BUSULFAN | 100702960 |
| 240002431 | 240011439 | 1.62 | 72.4 | null | 2020-05-22 | 2020-05-25 | CYTARABINE + DAUNORUBICIN | 02 | null | AML MYECHILD 01 IT CYT | 101729725 |
| 240002478 | 240011440 | 1.62 | 62 | null | 2019-05-15 | 2019-05-16 | LIPOSOMAL DAUNORUBICIN + CYTARABINE (Vyxeos) | null | null | ANTI-THYMOCYTE GLOBULIN + BUSULFAN + FLUDARABINE | 100059700 |